Loading...
Chemical structure of Canlitinib

GC73667

Canlitinib

Also known as 6-[4-[2-fluoro-4-[[1-[(4-fluorophenyl)carbamoyl]cyclopropanecarbonyl]amino]phenoxy]-6-methoxyquinolin-7-yl]oxyhexanoic acid

Canlitinib is a tyrosine kinase inhibitor, extracted from patent WO2018072614 (IV-2)

ChemicalCAS2222730-78-9MW619.61FormulaC33H31F2N3O7
CAS number
2222730-78-9
Molecular weight
619.61
Formula
C33H31F2N3O7
Solubility
DMSO ： 100 mg/mL (161·39 mM; Need ultrasonic)
InChIKey
PCKYITPVOLEZKL-UHFFFAOYSA-N
Catalogue number
GC73667
Brand
GLPBIO
Computed properties PubChem CID 139415233 · XLogP 6.1 · TPSA 136 Ų · H-bond donors 3
XLogP
6.1
TPSA
136 Ų
H-bond donors
3
H-bond acceptors
10
Rotatable bonds
14
Heavy atoms
45

SMILES COC1=CC2=C(C=CN=C2C=C1OCCCCCC(=O)O)OC3=C(C=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F)F

Computed descriptors from PubChem (CID 139415233), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.